EQS-News: Formycon AG / Key word(s): Market LaunchFormycon announces commercial launch of FYB201 (Ranibizumab) in Canada (RanoptoTM) and Switzerland (Ranivisio®) 11.04.2024 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press release // April 11, 2024 Formycon announces co.
EQS-News: Formycon AG / Key word: Market Launch
Formycon announces commercial launch of FYB201 in Canada and Switzerland
11.04.2024 / 07:30 CET/CEST
The issuer is.
EQS-News: Formycon AG / Key word: Regulatory Approval/Market Launch
FYB201/Ranibizumab keeps gaining momentum with approvals and launches in the MENA region
11.03.2024 /.
/PRNewswire/ Polpharma Biologics, an international biotech company dedicated to the development and manufacturing of biosimilars, today announced topline.